Bezdek Trevor
SEC CIK 1822104 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | Dir | 343.8K | — | $10.20M | 21 | 2021-09-01 | 2026-06-16 |
Most active insiders at GDRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRANCISCO PARTNERS IV, L.P. | 10% | — | $9.68M |
| 2 | SEA VII Management, LLC | 10% | — | $95.1K |
| 3 | Fengler Justin | See Remarks | — | — |
| 4 | Chan Thomas (TC) | CAO | — | — |
| 5 | Barnes Wendy Lynn | See Remarks, Dir | — | — |
| 6 | Nabiey Romin | CAO | — | — |
| 7 | Hirsch Douglas Joseph | Dir | — | — |
| 8 | Bezdek Trevor | Dir | — | — |
| 9 | McGinnis Christopher A | See Remarks | — | — |
| 10 | Bruehlman Ronald E | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 20:29 | 2026-06-16 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Dir | A - Grant | $0.00 | +73.4K | 343.8K | +27% | $0 | |
| 2026-06-10 18:52 | 2026-06-08 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Dir | A - Grant | $0.00 | +110.3K | 270.4K | +69% | $0 | |
| D | 2025-11-03 | 2025-11-02 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Dir | A - Grant | $0.00 | +33.5K | 160.1K | +26% | $0 |
| D | 2024-09-03 | 2024-09-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +126.6K | 126.6K | New | $0 |
| MI | 2024-06-11 | 2024-06-07+ | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | G - Gift | $0.00 | +5.27M | 2.63M | New | $0 |
| M | 2024-06-11 | 2024-06-07+ | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | G - Gift | $0.00 | -5.27M | 0 | -100% | $0 |
| D | 2024-06-03 | 2024-06-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +126.6K | 5.27M | +2% | $0 |
| D | 2024-03-01 | 2024-03-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +145.3K | 5.14M | +3% | $0 |
| D | 2023-12-04 | 2023-12-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +129.4K | 4.99M | +3% | $0 |
| D | 2023-10-23 | 2023-10-22 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +3.79M | 4.86M | +355% | $0 |
| D | 2023-09-01 | 2023-09-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +129.4K | 1.07M | +14% | $0 |
| D | 2023-06-05 | 2023-06-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | COB, Dir | C - Cnv Deriv | $0.00 | +129.4K | 940.1K | +16% | $0 |
| D | 2023-03-03 | 2023-03-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +156.9K | 810.7K | +24% | $0 |
| D | 2022-12-05 | 2022-12-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +129.4K | 653.8K | +25% | $0 |
| D | 2022-09-06 | 2022-09-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +129.4K | 524.4K | +33% | $0 |
| D | 2022-06-02 | 2022-06-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +129.4K | 395.1K | +49% | $0 |
| D | 2022-03-03 | 2022-03-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +134.7K | 265.7K | +103% | $0 |
| M | 2021-12-23 | 2021-12-22+ | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | S - Sale | $34.58 | -129.4K | 131.0K | -50% | -$4.47M |
| D | 2021-12-03 | 2021-12-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +129.4K | 260.3K | +99% | $0 |
| M | 2021-09-28 | 2021-09-24+ | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | S - Sale | $44.26 | -129.4K | 136.0K | -49% | -$5.73M |
| D | 2021-09-03 | 2021-09-01 | GDRX | GoodRx Holdings, Inc. | Bezdek Trevor | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +129.4K | 391.4K | +49% | $0 |
Purchase Sale Sale after option exercise All abbreviations